CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 3.32: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.90BCNY579.09M · vs all stocks (USD)
Revenue (TTM)
1.27BCNY188.40M · vs all stocks (USD)
Profit Margin
-3.91%Beta
0.00xvs all stocks
52-Week Change
-22.82%vs all stocks
Market Capitalization
3.90BCNY579.09M · vs all stocks (USD)
Enterprise Value
4.16BCNY617.60M · vs all stocks (USD)
Price to Sales (TTM)
3.10xPrice to Book (MRQ)
3.73xEnterprise to Revenue
3.28xEnterprise to EBITDA
31.76xGross Margin
47.14%Profit Margin
-3.91%Operating Margin
8.28%Return on Assets (TTM)
-0.36%Return on Equity (TTM)
-4.50%Revenue (TTM)
1.27BCNY188.40M · vs all stocks (USD)
Revenue per Share (TTM)
3.48CNYUpdated Aug 19, 2026Quarterly Revenue Growth
36.90%Gross Profit (TTM)
466.88MCNY69.24M · vs all stocks (USD)
EBITDA (TTM)
156.16MCNY23.16M · vs all stocks (USD)
Net Income (TTM)
-49.74MCNY-7.38M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
735.20%Operating Cash Flow (TTM)
142.59MCNY21.15M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
109.07MCNY16.18M · vs all stocks (USD)
5-Year Average Dividend Yield
1.99%vs all stocks
Payout Ratio
500.00%Revenue
1.18BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
722.18MCNYFY2025 · Dec 31, 2025Gross Profit
454.19MCNYFY2025 · Dec 31, 2025Operating Income
21.99MCNY3.26M · vs all stocks (USD)
Pre-tax Income
-59.59MCNYFY2025 · Dec 31, 2025Income Tax Expense
3.88MCNYFY2025 · Dec 31, 2025Net Income
-63.47MCNYFY2025 · Dec 31, 2025EBIT
-46.48MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
156.16MCNYFY2025 · Dec 31, 2025Research & Development
94.12MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
253.00MCNYFY2025 · Dec 31, 2025Other Operating Expenses
16.32MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.48MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
13.11MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1900CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1900CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
334.06MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
334.06MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-63.47MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-76.51MCNYFY2025 · Dec 31, 2025Free Cash Flow
-94.47MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
204.09MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-63.47MCNYFY2025 · Dec 31, 2025Other Non-cash Items
21.09MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-55.84MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
21.71MCNYFY2025 · Dec 31, 2025Capital Expenditures
-17.96MCNYFY2025 · Dec 31, 2025Purchase of Investments
-140.00MCNYFY2025 · Dec 31, 2025Sale of Investments
140.20MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-17.77MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
211.58MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-151.13MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-64.09MCNYFY2025 · Dec 31, 2025Other Financing Charges
-56.38MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-60.02MCNYFY2025 · Dec 31, 2025Shares Outstanding
334.89MSharesUpdated Aug 19, 2026Float Shares
233.29MSharesUpdated Aug 19, 2026% Held by Insiders
56.00%vs all stocks
% Held by Institutions
0.63%vs all stocks
Total Cash (MRQ)
245.90MCNY36.47M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.7340CNYUpdated Aug 19, 2026Total Debt (MRQ)
475.43MCNY70.51M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4511xCurrent Ratio (MRQ)
1.70xBook Value per Share (MRQ)
3.15CNYUpdated Aug 19, 2026Total Assets
2.03BCNY300.84M · vs all stocks (USD)
Total Current Assets
856.26MCNYFY2025 · Dec 31, 2025Total Liabilities
990.19MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.17BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
454.72MCNYFY2025 · Dec 31, 2025Total Current Liabilities
535.47MCNYFY2025 · Dec 31, 2025Cash
203.77MCNYFY2025 · Dec 31, 2025Cash Equivalents
52.40MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
256.17MCNYFY2025 · Dec 31, 2025Other Short-term Investments
53.63KCNYFY2025 · Dec 31, 2025Accounts Receivable
137.08MCNYFY2025 · Dec 31, 2025Inventory
394.61MCNYFY2025 · Dec 31, 2025Accounts Payable
143.53MCNYFY2025 · Dec 31, 2025Short-term Debt
220.66MCNYFY2025 · Dec 31, 2025Other Current Liabilities
12.46MCNYFY2025 · Dec 31, 2025Long-term Debt
311.67MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
5.58MCNYFY2025 · Dec 31, 2025Common Stock (Book)
334.89MCNYFY2025 · Dec 31, 2025Retained Earnings
374.76MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.04BCNY153.99M · vs all stocks (USD)
52-Week Low
9.02CNYUpdated Aug 19, 202652-Week High
18.96CNYUpdated Aug 19, 202652-Week Change
-22.82%vs all stocks
Beta
0.00xvs all stocks
50-Day MA
10.51CNYUpdated Aug 19, 2026200-Day MA
12.94CNYUpdated Aug 19, 2026Avg 10-Day Volume
10.94MSharesUpdated Aug 19, 2026Avg 30-Day Volume
12.96MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.1500CNYUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.47Profit Margin: -0.04
Financial Health
Altman Z-Score 3.32: safe zoneNotable
Altman Z-Score: 3.32
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhejiang Orient Gene Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
ChemoCentryx Inc
Tier 1ProductionApproval-Gated PipelineRule
4D Molecular Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zeria Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hunan Hansen Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Sunflower Great Health Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Nanjing Hicin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Ningbo David Medical Device Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
FDC Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Nanjing Xinjiekou Department Store Co. Ltd.
1 interpretationDown-Close Share With Multi-Year Earnings Decrease
Sdic Intelligence Co., Ltd.
1 interpretationDown-Close Share With Multi-Year Earnings Decrease
Crown Advanced Material Co. Ltd.
1 interpretationDown-Close Share With Multi-Year Earnings Decrease